Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 337, 521-529
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (51633005)
- National Natural Science Foundation of China (51861145310)
This publication has 49 references indexed in Scilit:
- Delivery materials for siRNA therapeuticsNature Materials, 2013
- In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?Molecular Therapy, 2012
- Engineering Nanocarriers for siRNA DeliverySmall, 2011
- Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptorsJournal of Neurochemistry, 2011
- RNAi and small interfering RNAs in human disease therapeutic applicationsTrends in Biotechnology, 2010
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- RNAi therapeutics: a potential new class of pharmaceutical drugsNature Chemical Biology, 2006
- Targeting polo-like kinase 1 for cancer therapyNature Reviews Cancer, 2006
- Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance SystemJournal of Clinical Oncology, 2004
- Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cellsProceedings of the National Academy of Sciences, 2003